Dry Needling of Trigger Points for Myofascial Pain
Policy for Commercial Products defining coverage determination for dry needling of myofascial trigger points (not applicable to Medicare Advantage). It states medical necessity conclusions, applicable CPT coding guidance, and cites supporting evidence.
Policy is applicable to Commercial Products only; Medicare Advantage plans have a related policy.
Coverage Summary
Overview: This policy addresses dry needling of myofascial trigger points for Commercial Products. The policy scope defines the coverage determination for dry needling and related CPT coding guidance, and concludes that dry needling of trigger points for treatment of myofascial pain is not medically necessary for Commercial Products because the evidence is insufficient to determine effects on health outcomes. Effective date: 06/21/2016. Last review date: 05/06/2026. Note: Policy is applicable to Commercial Products only; Medicare Advantage readers are referred to the related policy named Acupuncture and Dry Needling for Medicare Advantage Plans.